by Sara M. Nolte | Sep 12, 2017
Over two years ago, an article published in Science took the Internet and media by storm. The paper, “Variation in cancer risk among tissues can be explained by the number of stem cell divisions,” better known as “The ‘Bad Luck’ Cancer Study,” used mathematical...
by Stacey Johnson | Aug 25, 2017
On Tuesday, August 29, Signals is hosting a blog carnival on the topic Right to Try. Before you read the perspectives of the contributing bloggers, here’s what President Trump thinks about the legislation and the Goldwater Institute’s reaction. It’s the Institute that...
by Stacey Johnson | Jul 14, 2017
I’ve been thinking about unapproved stem cell treatments a lot recently. First, I read this article that hailed the arrival of stem cell treatments in a small community in western Canada. There were many statements in the article that concerned me, but I only...
by Stacey Johnson | May 26, 2017
Recently, a friend posted on Facebook the news about her teenage son who, a year ago, had been suffering from an undiagnosed condition. Her son’s doctor didn’t treat the symptoms very seriously until the mother insisted something was wrong and implored him to identify...
by Stacey Johnson | Mar 31, 2017
via GIPHY Artificial Intelligence (AI) already permeates our culture and that’s only going to increase with time and advances to the technology. Some think this is good news, progress and inevitable while others, like Stephen Hawking for example, fear where AI could...
by Stacey Johnson | Feb 24, 2017
This week, BrainStorm Cell Therapeutics issued a news release announcing its intent to seek early regulatory approval to distribute its Amyotrophic Lateral Sclerosis (ALS) product to patients in Canada. This news was eagerly received by patient groups in Canada and...
Comments